Zobrazeno 1 - 10
of 82
pro vyhledávání: ''
Autor:
Yan Yuan, Zhifan Zeng, Rong-Zhen Li, Weiwei Xiao, Hui Chang, Qiaoxuan Wang, Yuanhong Gao, Wei-Hao Xie
Publikováno v:
Cancer Medicine, Vol 11, Iss 1, Pp 117-127 (2022)
Cancer Medicine
Cancer Medicine
Background Anal squamous cell carcinoma (ASCC) is a rare malignant tumor with increasing incidence. The goal of our study was to analyze the treatment outcome and prognostic factors of ASCC in South China in the past half‐century. Methods This stud
Publikováno v:
Cancer Medicine, Vol 10, Iss 16, Pp 5545-5556 (2021)
Cancer Medicine
Cancer Medicine
Epigenetic regulation is important for cancer tumor metastasis and progression, including lung and liver cancer. However, the mechanism of epigenetic regulation in liver cancer leaves much to be discussed. According to a previous study, p300/CBP‐as
Autor:
Guozhen Xu, Chen Hu, Ye Zhang, Qingfeng Liu, Jingwei Luo, Li Gao, Kai Wang, Jingbo Wang, Junlin Yi, Jianghu Zhang, Jianping Xiao, Xuesong Chen, S. Sun, Xiaodong Huang, Ye Xiong Li, Runye Wu, Yuan Qu
Publikováno v:
Cancer Medicine, Vol 10, Iss 11, Pp 3613-3621 (2021)
Cancer Medicine
Cancer Medicine
Purpose Conditional survival (CS) and failure hazard estimations can provide important dynamic prognostic information for clinical decision‐making and surveillance counseling. The current study aimed to investigate the CS and dynamic failure hazard
Publikováno v:
Cancer Medicine, Vol 10, Iss 10, Pp 3474-3485 (2021)
Cancer Medicine
Cancer Medicine
Background The clinical characteristics and prognosis of primary intestinal diffuse large B‐cell lymphoma (PI‐DLBCL) are rarely reported. We aimed to explore the role of surgery in patients with PI‐DLBCL. Methods Adult PI‐DLBCL patients were
Autor:
Caitlin E. Walsh, Vundavalli V. Murty, Bachir Alobeid, Govind Bhagat, Andrew M. Parrott, Alecia Christiano
Publikováno v:
Cancer Medicine, Vol 10, Iss 8, Pp 2680-2689 (2021)
Cancer Medicine
Cancer Medicine
Context The detection of low‐level persistent or relapsed B‐cell neoplasms, particularly post‐therapy, can be challenging, often requiring multiple testing modalities. Objective Here we investigate the utility of CD19‐based selection of neopl
Autor:
Pian Zhang, Dehui Zou, Yuqin Song, Hui Liu, Wenyu Li, Su Yang, Daobin Zhou, Zhitao Ying, Jun Zhu, Jianqiu Wu, Zhao Wang, Haiyan Yang, Mingzhi Zhang, Hongxia Zheng, Ye Guo, Zisong Zhou
Publikováno v:
Cancer Medicine, Vol 10, Iss 3, Pp 999-1011 (2021)
Cancer Medicine
Cancer Medicine
Background Despite numerous chimeric antigen receptor T‐cell (CAR‐T) trials conducted in China, no CAR‐T has been registered in the country. Furthermore, China law and regulations restrict the export of patient material for CAR‐T manufacture
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 5, Pp 1848-1859 (2021)
Cancer Medicine, Vol 10, Iss 5, Pp 1848-1859 (2021)
Background Since autophagy remains an important topic of investigation, the RNA‐sequence profiles of autophagy‐related genes (ARGs) can provide insights into predicting low‐grade gliomas (LGG) prognosis. Methods The RNA‐seq profiles of autoph
Publikováno v:
Cancer Medicine, Vol 10, Iss 3, Pp 974-988 (2021)
Cancer Medicine
Cancer Medicine
Background Metastatic adenocarcinoma of unknown primary site (MACUP) is the most common cancer of unknown primary site, and shows worse prognosis. Prediction of its tumor site origin attracts a growing attention. However, the site determined by gene
Autor:
Dianrong Xiu, Yanpeng Ma, Lu Xu, Guozhen Liu, Wei Fu, Tao Sun, Siyan Zhan, Lili Liu, Jinxi Wang, Pei Gao, Jingnan Feng, Shengfeng Wang
Publikováno v:
Cancer Medicine, Vol 10, Iss 2, Pp 737-744 (2021)
Cancer Medicine
Cancer Medicine
Background Information on incidence of gastrointestinal stromal tumor (GIST), the most common type of mesenchymal tumor in gastrointestinal tract, was limited in China. This study aimed to estimate the incidence of GIST in urban population from mainl
Autor:
Michihide Tokuhira, Eriko Sato, Norio Asou, Tomoiku Takaku, Hiroyuki Fujita, Yoshihiro Hatta, Tatsuya Kawaguchi, Masahiro Kizaki, Tomonori Nakazato, Noriyoshi Iriyama, Maho Ishikawa, Keiji Sugimoto, Isao Fujioka, Yuta Kimura, Norio Komatsu
Publikováno v:
Cancer Medicine
The European Treatment and Outcome Study (EUTOS) long‐term survival (ELTS) score predicts disease‐specific death in patients with chronic myeloid leukemia (CML) being treated with imatinib during the chronic phase (CP) of the disease. However, it